I undertook to examine a series of cases. These included 8 patients naturalistically referred and treated in a cognitivebehavioural therapy group for patients with bipolar disorder (BD) and 6 patients consecutively referred for consultation and subsequently diagnosed with BD. I assessed these patients further, using the Mood Disorders Questionnaire (MDQ) (4) . The MDQ confirmed a history of hypomania or mania, and several additional written questions were asked, including the following: "What is the least time it (the antidepressant) took to work after you started (in days)?" and "When did this most rapid response occur?"(among previous trials of antidepressant therapy). The cohort ranged in age from 24 to 48 years (average age 39.8 years). There were 8 women and 6 men.
Their diagnoses according to DSM-IV-TR criteria (7) were as follows: BD I (n = 4), BD II (n = 7), and BD not otherwise specified (NOS) (n = 3).
Of the patients, 13/14 (93%) reported a therapeutic response to antidepressants at some time; 10/13 (77%) reported responding in 3 days' time or less, at some time. The other subjects' shortest response times were reported as 21, 10, and 7 days, respectively. The average response time was 4.4 days. Of the 11 patients reporting a response in 7 days or less, 9 (82%) had that ultrarapid response early in their course (that is, during the first or second trial). Of 14 subjects, 13 (93%) reported becoming agitated at some time in response to an antidepressant.
These findings suggest a very strong association between retrospectively reported ultrarapid response to antidepressants and bipolarity. Although retrospective data are subject to more flaws than prospective data, an examination of the longitudinal course of recurrent affective illness at the National Institutes of Mental Health showed a high correlation between retrospective "life chart" data and data gathered prospectively (5) . In this series, most patients did not have a diagnosis of BD I, and the female-to-male ratio did not quite reflect the higher preponderance of female patients among individuals with BD II and BD NOS (6) . Additionally, the MDQ does not include the DSM-IV-TR's duration-of-episode criterion for hypomania (7) ; therefore, some subjects may have had a bipolar spectrum disorder (8) .
A more rigorous test would be a prospective study in primary care, with surveillance for ultrarapid response when antidepressants are first prescribed for depression and with patients followed to identify subsequent manic or hypomanic episodes. This is important because there is evidence of a possible iatrogenic worsening of the course when BD is recognized late and antidepressant treatment has been inappropriate (3). Patients reporting agitation as an antidepressant "side effect" would be interesting to screen for hypomania.
Andre Piver, MD Nelson, British Columbia

Developmental Alcohol Exposure, Circadian Rhythms, and Mood Disorders
Dear Editor:
Alcohol exposure during rapid brain growth causes cell loss, alters connections between brain regions, and decreases the production of brain chemicals responsible for the communication among neurons (1, 2) . Thus, it is reasonable to suggest that alcohol may adversely affect the development of the suprachiasmatic nucleus (SCN), the master circadian pacemaker. Adult rats exposed to alcohol during the early postnatal period-a critical period of brain development-exhibited a shortened circadian sleep-wake cycle (1).
Other experimental and clinical studies have reported that prenatal exposure to alcohol results in sleep abnormalities (1, 3) .
Studies suggest that abnormalities in circadian rhythm are involved in the etiopathogenesis of seasonal affective disorder (SAD) (4, 5) . The phase-delay hypothesis of SAD postulates that some components of circadian rhythm are phase delayed relative to sleep in SAD. The photoperiod hypothesis of SAD suggests that the shortening of the photoperiodic environment during winter months triggers SAD. Some researchers have proposed that the pathophysiology of SAD is related to the changes in strength or precision of circadian rhythms.
Abnormalities of circadian rhythm have also been implicated in the etiopathogenesis of nonseasonal mood disorders (5-7 
Attouchements sexuels pratiqués par un adolescent substitué en testostérone
Cher Editeur:
Les anabolisants stéroïdiens sont des médicaments utilisés depuis plus de cinquante ans dans le traitement de nombreuses maladies organiques, dans la contraception masculine mais aussi, autrefois, dans certaines pathologies psychiatriques (1) . Plus récemment, des athlètes les ont utilisés pour développer leurs capacités musculaires. Ce nouvel attrait a entraîné aux É.-U. une explosion de la consommation de ces médicaments
